Completed PHASE4 INTERVENTIONAL 2-arm NCT00718289

Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes

Sponsor: Bichsel AG, Interlaken, Switzerland

Interventions Acetate dialysate Citrate dialysate

Updated 5 times since 2017 Last updated: Jul 17, 2008 Started: Mar 31, 2007 Primary completion: Nov 30, 2007 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00718289, this PHASE4 trial focuses on Haemodialysis and remains completed. Sponsored by Bichsel AG, Interlaken, Switzerland, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bichsel AG, Interlaken, Switzerland
Ospedale Regionale di Locarno

Data source: Ospedale Regionale di Locarno

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Locarno, Switzerland